University of Texas Southwestern Medical Center, Dallas, TX.
J Clin Oncol. 2014 Apr 1;32(10):973-82. doi: 10.1200/JCO.2013.53.1228. Epub 2014 Feb 24.
Progress in lung cancer therapy has been slow but steady and has accelerated due to improvements in scientific basis for the disease and to technologic advances in diagnosis and therapy. The elusive goal of reduced mortality rates can be achieved in the next 50 years through continued interdisciplinary research efforts.
肺癌治疗的进展虽然缓慢但却稳定,并因对疾病的科学基础的改善以及在诊断和治疗方面的技术进步而加速。通过持续的跨学科研究努力,未来 50 年内可以实现降低死亡率这一难以实现的目标。